Two-hour post-dose cyclosporin A levels in adolescent renal transplant recipients in the late post-transplant period

被引:10
作者
Kavukçu, S
Soylu, A
Türkmen, M
Kasap, B
Gümüstekin, M
Gülay, H
机构
[1] Dokuz Eylul Univ, Sch Med, Dept Pediat, Izmir, Turkey
[2] Dokuz Eylul Univ, Sch Med, Dept Pharmacol, Izmir, Turkey
[3] Dokuz Eylul Univ, Sch Med, Dept Gen Surg, Izmir, Turkey
关键词
adolescent; 2-h post-dose cyclosporin A levels; renal transplantation;
D O I
10.1007/s00467-004-1452-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Although the success of renal transplantation is closely linked to the immunosuppression provided by cyclosporin A (CsA), the best way to monitor the blood levels of CsA is still not clear. Trough CsA levels (C-0) are commonly used, but the 2-h post-dose CsA levels (C-2) are reported to correlate better with area under the curve. The aim of this study was to evaluate the correlation of C-2 levels with allograft function in adolescent renal transplant recipients in the late post-transplant period (6 months after transplantation) compared with C-0 levels. The data of 17 adolescent renal transplant recipients (12 males, 5 females) were evaluated retrospectively. The mean age at the time of transplantation was 15.212+/-2.918 years and the mean follow-up period was 53.172+/-34.090 months. C-0 levels correlated with oral CsA and diltiazem doses, while C-2 levels exhibited no correlation. When C-2 levels were classified as 0-400, 401-800, and 801-1200 ng/ml, no statistically significant difference was found between these groups with respect to glomerular filtration rate (P=0.830). Although 82% of the patients had C-2 beneath the therapeutic level (<800 ng/ml), none had an acute rejection episode. In conclusion, optimum C-2 levels could be different from levels in the adult population. Furthermore, the correlation of C-2 levels with CsA dose seems to be weaker than in the adult population. Thus, further studies are needed to determine a more reliable predictor for CsA dose monitoring and target blood CsA levels in adolescent patients.
引用
收藏
页码:667 / 671
页数:5
相关论文
共 30 条
[1]   Neoral absorption profiling: An evolution in effectiveness [J].
Belitsky, P ;
Levy, GA ;
Johnston, A .
TRANSPLANTATION PROCEEDINGS, 2000, 32 (3A) :45S-52S
[2]   Neoral induction in pediatric renal transplantation [J].
Bunchman, TE ;
Parekh, RS ;
Flynn, JT ;
Smoyer, WE ;
Kershaw, DB ;
Valentini, RP ;
Pontillo, BJ ;
Sandvordenker, J ;
Brown, C ;
Sedman, AB .
PEDIATRIC NEPHROLOGY, 1998, 12 (01) :2-5
[3]   Comparison of neoral dose monitoring with cyclosporine trough levels versus 2-hr postdose levels in stable liver transplant patients [J].
Cantarovich, M ;
Barkun, JS ;
Tchervenkov, JI ;
Besner, JG ;
Aspeslet, L ;
Metrakos, P .
TRANSPLANTATION, 1998, 66 (12) :1621-1627
[4]  
Cantarovich M, 1998, CLIN TRANSPLANT, V12, P243
[5]   Clinical benefit of neoral dose monitoring with cyclosporine 2-HR post-dose levels compared with trough levels in stable heart transplant patients [J].
Cantarovich, M ;
Elstein, E ;
de Varennes, B ;
Barkun, JS .
TRANSPLANTATION, 1999, 68 (12) :1839-1842
[6]   Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients [J].
Cole, E ;
Naham, N ;
Cardella, C ;
Cattran, D ;
Fenton, S ;
Hamel, J ;
O'Grady, C ;
Smith, R .
TRANSPLANTATION, 2003, 75 (12) :2086-2090
[7]   Cyclosporin pharmacokinetics in paediatric transplant recipients [J].
Cooney, GF ;
Habucky, K ;
Hoppu, K .
CLINICAL PHARMACOKINETICS, 1997, 32 (06) :481-495
[8]  
Curtis JJ, 1997, KIDNEY INT, pS75
[9]  
DALTON RN, 1999, PEDIAT NEPHROLOGY, P343
[10]   Neoral monitoring 2 hours post-dose and the pediatric transplant patient [J].
Dunn, SP .
PEDIATRIC TRANSPLANTATION, 2003, 7 (01) :25-30